Emmes, MedGenome to Speed Up Genomics-based Breakthrough Therapies

Emmes, MedGenome to Speed Up Genomics-based Breakthrough Therapies

312774

Emmes, MedGenome to Speed Up Genomics-based Breakthrough Therapies

A partnership between Emmes and MedGenome seeks to accelerate development of genomics-powered therapies for people with rare diseases, such as hemophilia. The companies plan to combine patient data into custom disease registries to improve research design and help with patient recruitment for clinical trials. In addition, they hope to produce standardized controls for advanced statistical models to measure the effectiveness of treatments. The information collected will include epidemiological data, which deal with observed disease patterns,…

You must be logged in to read/download the full post.